Related Experiment Video
Updated: May 23, 2026

10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Can IMA-RNTCP stop TB by 2050?
R S Sisodia1, D K Jain, S S Agarwal
1IMA, New Delhi 110029.
Journal of the Indian Medical Association
|April 10, 2012
Summary
Effective tuberculosis control programs, like India's RNTCP using DOTS strategy, significantly reduce disease incidence and mortality. Achieving high case detection and cure rates makes tuberculosis a winnable public health battle.
Area of Science:
- Public Health
- Epidemiology
- Infectious Diseases
Background:
- Tuberculosis (TB) poses significant sociological, economic, and health challenges globally.
- Poorly functioning TB control programs exhibit high incidence-to-prevalence ratios (e.g., 1:3.5).
- Achieving 70% case detection and 85% cure rates for smear-positive TB cases can lead to a 5% annual incidence decline and rapid prevalence reduction.
Purpose of the Study:
- To evaluate the impact of the Revised National Tuberculosis Control Programme (RNTCP) in India on TB prevalence and mortality.
- To highlight the effectiveness of the Directly Observed Treatment, Short-course (DOTS) strategy in TB control.
- To project the potential for TB elimination as a public health problem by 2050.
Main Methods:
- Analysis of TB prevalence and mortality data in India from 1990 to 2015.
- Assessment of RNTCP's adherence to DOTS principles and public-private partnerships.
- Evaluation against Millennium Development Goal indicators for TB control.
Main Results:
- TB prevalence in India declined by 68% from 586/100,000 in 1990 to 185/100,000 in 2008.
- TB mortality rate reduced by 43% from 42/100,000 in 1990 to 24/100,000 in 2008, progressing towards the 2015 target.
- Effective implementation of RNTCP has demonstrated significant positive impact on TB control metrics.
Conclusions:
- The RNTCP in India, guided by DOTS, has successfully reduced TB prevalence and mortality.
- Coordinated efforts between public and private sectors are crucial for effective TB management.
- Sustained progress in TB control can lead to its elimination as a public health problem by 2050, signifying a winnable battle.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Transmission-based Precautions II: Airborne and Protective Environment
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
